The tumor-suppressor activity of miR-6869-5p was supported by direct targeting of TLR4, subsequently inhibiting TNF‐α and IL-6 production in CRC cells via the TLR4/NF-κB signaling pathway, leading to a decrease in cellular proliferation. The gene discussed is TLR4; the disease is neoplasm.